Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Gotch

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cell Host & Microbe|November 11, 2008
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirusDimitrios Lagos, Richard James Vart, Fiona Gratrix, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Journal of Virology|March 14, 2003
Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopesJustin Stebbing, Dimitra Bourboulia, Margaret Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infectionEmma E Page, Louise Greathead, Rebecca Metcalf, et al.
Science (New York, N.Y.)|July 13, 2004
Support for the RV144 HIV vaccine trialRobert Belshe, Genoveffa Franchini, Marc P Girard, et al.
Vaccine|September 13, 2005
European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines researchThomas Lehner, Michael Hoelscher, Mario Clerici, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1Adel Benlahrech, Julian Harris, Andrea Meiser, et al.
Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.
Journal of Translational Medicine|July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cell Host & Microbe|November 11, 2008
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirusDimitrios Lagos, Richard James Vart, Fiona Gratrix, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Journal of Virology|March 14, 2003
Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopesJustin Stebbing, Dimitra Bourboulia, Margaret Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infectionEmma E Page, Louise Greathead, Rebecca Metcalf, et al.
Science (New York, N.Y.)|July 13, 2004
Support for the RV144 HIV vaccine trialRobert Belshe, Genoveffa Franchini, Marc P Girard, et al.
Vaccine|September 13, 2005
European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines researchThomas Lehner, Michael Hoelscher, Mario Clerici, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1Adel Benlahrech, Julian Harris, Andrea Meiser, et al.
Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.
Journal of Translational Medicine|July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Pageof 8